Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Shaw

Showing results (191-200 of 196) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 196 results.
Bone Marrow Transplantation|September 7, 2010
A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescentsJ Styczynski, B Tallamy, I Waxman, et al.
The Journal of Prevention of Alzheimer'S Disease|September 29, 2021
Editorial: How Will Aducanumab Approval Impact AD Research?M W Weiner, P S Aisen, L A Beckett, et al.
Neurology|December 3, 2010
Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohortS Kim, S Swaminathan, L Shen, et al.
Translational Psychiatry|July 27, 2012
Plasma biomarkers of depressive symptoms in older adultsS E Arnold, S X Xie, Y-Y Leung, et al.
Bone Marrow Transplantation|June 12, 2012
The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipientsJ B Le Gall, M C Milone, I M Waxman, et al.
Molecular Psychiatry|November 12, 2014
FASTKD2 is associated with memory and hippocampal structure in older adultsV K Ramanan, K Nho, L Shen, et al.
Pageof 20

Showing results (191-200 of 196) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 196 results.
Bone Marrow Transplantation|September 7, 2010
A pilot study of reduced toxicity conditioning with BU, fludarabine and alemtuzumab before the allogeneic hematopoietic SCT in children and adolescentsJ Styczynski, B Tallamy, I Waxman, et al.
The Journal of Prevention of Alzheimer'S Disease|September 29, 2021
Editorial: How Will Aducanumab Approval Impact AD Research?M W Weiner, P S Aisen, L A Beckett, et al.
Neurology|December 3, 2010
Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohortS Kim, S Swaminathan, L Shen, et al.
Translational Psychiatry|July 27, 2012
Plasma biomarkers of depressive symptoms in older adultsS E Arnold, S X Xie, Y-Y Leung, et al.
Bone Marrow Transplantation|June 12, 2012
The pharmacokinetics and safety of twice daily i.v. BU during conditioning in pediatric allo-SCT recipientsJ B Le Gall, M C Milone, I M Waxman, et al.
Molecular Psychiatry|November 12, 2014
FASTKD2 is associated with memory and hippocampal structure in older adultsV K Ramanan, K Nho, L Shen, et al.
Pageof 20